RARE
Ultragenyx
15.20$
+3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 11.2% | 9.5% | 16.1% | 14.5% | 15.1% | 10.2% | 20.6% | 13.8% | 17.5% | 14.0% | 22.1% | 15.9% | 16.9% | |
| 88.8% | 90.5% | 83.9% | 85.5% | 84.9% | 89.8% | 79.4% | 86.2% | 82.5% | 86.0% | 77.9% | 84.1% | 83.1% | |
| 160.4% | 126.0% | 164.0% | 109.8% | 121.9% | 113.9% | 119.0% | 98.9% | 135.2% | 98.1% | 137.5% | 78.0% | 107.8% | |
| 76.4% | 60.3% | 71.8% | 54.8% | 57.6% | 50.0% | 63.0% | 52.0% | 54.2% | 42.5% | 64.7% | 41.1% | 48.9% | |
| 236.8% | 186.3% | 235.8% | 164.7% | 179.5% | 163.9% | 182.0% | 151.0% | 189.3% | 141.1% | 202.2% | 119.2% | 156.9% | |
| -148.0% | -95.8% | -151.9% | -79.1% | -94.6% | -74.2% | -102.6% | -64.8% | -106.9% | -55.1% | -124.3% | -35.0% | -73.8% | |
| 18.0% | 13.6% | 14.6% | 10.9% | 11.3% | 9.4% | 10.3% | 8.4% | 8.8% | 9.2% | 15.4% | 10.3% | 10.6% | |
| -162.2% | -99.6% | -156.4% | -88.9% | -95.5% | -80.9% | -107.5% | -68.5% | -112.3% | -61.8% | -135.3% | -42.5% | -81.3% | |
| 0.7% | -2.9% | 0.4% | 0.6% | 0.2% | 0.0% | 0.9% | 0.6% | 0.5% | 0.5% | 0.7% | 0.5% | 0.5% | |
| -162.8% | -96.7% | -156.8% | -89.5% | -95.7% | -80.9% | -108.5% | -69.0% | -112.8% | -62.3% | -136.0% | -43.0% | -81.8% | |
| -136.8% | -79.6% | -133.7% | -72.0% | -78.0% | -66.0% | -90.8% | -54.9% | -98.0% | -48.4% | -114.0% | -28.5% | -66.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.